Septic shock at uroinfections
Authors:
prof. MUDr. Pavel Ševčík, CSc.; prim. MUDr. Alena Ševčíková
Authors place of work:
Oddělení klinické mikrobiologieLF MU a FN Brno
; Anesteziologicko-resuscitační klinika LF MU a FN u sv. Anny v Brně
Published in the journal:
Urol List 2005; 3(2): 66-70
Summary
Complicated infections of urinary tract, especially pyelonephritis, are relatively fre-quent cause of severe sepsis and septic shock in critical patients [1,2,3]. At Intensive care unite (ICU), the infections of urinary tract are most frequently of nosocomial origin. In often quoted prevalence study EPIC made in 1992, at 1417 Intensive care unite (ICU) in western Europe, the nosocomial infections were stated at 30,3 % of patients, while nosocomial infections of urinary tract occured at 17,6 % of them - they ranked third position after nosocomial pneumonias (46,9 %) and infections of lower respiratory tract (17,8 %) [4]. Nosocomial infections of urinary tract most frequently hang together with the use of urine drainage devices, most often with bladder catheterization. Up to 95 % of cases of nosocomial urinary infections occur in catheterized patients. In intensive care, depending on the type of department, there are 45-86 % of patients catheterized [5]. At our department, providing the highest type of intensive care, urinary catheter is inserted in almost 100% of patients. The incidence of urine infections in catheterized patients range between 3,3 ‰ of catheterization days at cardiosur-gical IMW and 10 ‰ of catheterization days at burn wards [6]. Urine infections are significant source of bacteriemia and they may contribute to deterioration of renal functions. They prolong the hospitalization in average for 1-4 days and they increase treatment costs [1,7].
KEY WORDS:
sepsis, severe sepsis, septic shock, urosepsis, SIRS
Zdroje
1. Vallés J, León C, Alvarez-Lerma F. Spanish Collaborative Group for Infections in Intensive Care Units. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Clin Infect Dis 1997; 24: 387-395.
2. Paradisi F, Corti G, Mangani V. Urosepsis in the critical care unit. Crit Care Clin 1998; 14: 165-180.
3. Rosser C, Bare R, Meredith J. Urinary tract infections in the critically ill patient with urinary catheter. Am J Surg 1999; 177: 287-290.
4. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infections in intensive care units in Europe - results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995; 274: 639-644.
5. Richards M, Edwards JR, Culver DH et al. Nosocomial infections in medical intensive care units in the Unites States. Crit Care Med 1999; 27: 887-892.
6. Alvarez-Rocha L, Rascado-Sedes P, Castro-Orjales MJ. Urinary Tract Infections. In: Rello J, Valles J, Kollef M (eds). Critical Care Infectious Diseases. Boston: Kluwer Academic Publishers 2001: 731-748.
7. Jarvis W. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996; 17: 552-557.
8. The EPISEPSIS Study Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30: 580-588.
9. Bone RC, Balk RA, Cerra FB et al. The ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1656-1662.
10. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
11. Dellinger RP, Carlet JM, Masur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536-555.
12. Mackenzie I, Wilson I. The management of sepsis. Update in Anaesthesia 2001; 13: 16-25.
13. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
14. Choi PT, Yip G, Quinonez LG et al. Crystalloids vs colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27: 200-210.
15. Blot F, Schmidt E, Nitenberg G et al. Earlier positivity of central venous versus peripheral blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36: 105-109.
16. Ibrahim EH, Sherman G, Ward S et al. The influence of adequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155.
17. Amsden GW, Ballow CH, Bertino JS. Pharmacokinetics and pharmacodynamics of anti-infective agents. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone 2000: 253-261.
18. Jimenez MF, Mashall JC. Source control in the management of sepsis. Intensive Care Med 2001; 27: S49-S62.
19. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infection. Morb Mortal Wkly Rep 2002; 51: 1-29.
20. Ševčík P, Kraus R, Sas I, Zvoníček V. Možnosti prevence nozokomiálních infekcí spojených s intravaskulárními katétry. Anesteziologie a neodkladná péče 1999; 10: 174-179.
21. Holmes CL, Walley KR, Chittock DR et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001; 27: 1416-1421.
22. Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in pateints with septic shock. JAMA 2002; 288: 862-871.
23. Bernard GR, Vincent JL, Laterre PF et al. Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
24. Corvin HL, Gettinger A, Pearl RG et al. EPI Critical Care Trials Group. Efficacy of recombinant human erythropoietin in critically ill patients. JAMA 2002; 288: 2877-2835.
25. Warren BL, Eid A, Singer P et al. High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 2001; 286: 1869-1878.
26. Practice Guidelines for Blood Component Therapy. A report by the American Society of Anaesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84: 732-747.
27. Amato MB, Barbas CS, Medeiros DM et al. Effect of a protective ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338: 347-354.
28. Drakulovic M, Torres A, Bauer T et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet 1999; 354: 1851-1858.
29. Kress JP, Pohlman AS, O´Connor MF et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Eng J Med 2000; 342: 1471-1477.
30. Berghe G van den, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
31. Kellum J, Angus DC, Johnson JP et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002; 28: 29-37.
32. Ševčík P, Volčík A. Profylaxe stresového vředu u kriticky nemocných. In: Cvachovec K (ed). Novinky v anesteziologii, intenzivní medicíně a léčbě bolesti. Praha: Galén 2004: 113-116.
33. Ševčík P. Sepse v intenzivní péči. Martin: Osveta 1993.
34. Kula R, Sklienka P, Sturz P et al. Těžká sepse - lze jí předejít? Vybrané kapitoly o tom, jak jsme poučitelní. Postgraduální medicína 2004; 6: 616-621.
Štítky
Paediatric urologist UrologyČlánok vyšiel v časopise
Urological Journal
2005 Číslo 2
Najčítanejšie v tomto čísle
- Mycotic infections
- URINARY TRACT INFECTIONS IN CHILDREN AND DURING PREGNANCY
- Septic shock at uroinfections
- The principles of antimicrobial treatment in uroinfections